pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Aug 3·1 min read
save

Amgen reports hackers stole patient and company data in cloud breach

Aug 3, 2026·read at Endpoints ↗Negative

Amgen disclosed on Friday that hackers have accessed and taken both company and patient information in a cyber-attack.

The company said the intrusion was detected as "unauthorized activity" affecting data stored on cloud platforms operated by third-party providers, with the activity first noticed in July.

Amgen is investigating the breach and has not released further details about the extent of the data taken, underscoring ongoing cybersecurity concerns for pharmaceutical firms that rely on external cloud services.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Amgen says hackers stole patient data in cloud breach”

read at Endpoints ↗
79 words · retrieved Aug 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AMGEN5

related stories

  • Jun 4STAT+: Does Revolution Medicines’ pancreatic cancer drug have even greater potential?STAT
  • May 29Bristol Myers unveils data for one of its next-gen blood cancer drugsBioPharma Dive
  • May 18Amgen stands by rare disease drug Tavneos amid Japan liver toxicity reportEndpoints
  • May 18Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drugBioPharma Dive
  • May 15Amgen expands crackdown on what it says is misuse of 340B programEndpoints